Medicines A–Z
C
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Colistimethate sodium | NHS England commissioned for cystic fibrosis only. Red for new patients. |
|
 |
Colomycin nebulised | NHS England Commissioned for Cystic Fibrosis only. Existing patients - initiated prior to April 2013 |
|
|
Colomycin nebulised | NHS England Commissioned for Cystic Fibrosis only, new patients |
|
 |
Co-magaldrox suspension | Second line - when a lower sodium content is required. High relative cost. |
|
|
Combigan eye drops | Specialist ophthalmologist recommendation |
|
|
Conestat Alfa (Ruconest) | NHS England commissioned. Hospital only. |
|
|
Conotrane cream | ||
|
Continous glucose monitoring system (Dexcom ONE®) | ||
|
Copper (chelated) capsules | ||
|
Copper intra-uterine devices | Second line - copper intra-uterine devices (72 – 120 hours) |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
